Journal of Vascular Surgery
Volume 45, Issue 6, Supplement , Pages A25-A32 , June 2007

Regulation of vascular smooth muscle cell differentiation

Received 6 February 2007 ,Accepted 1 March 2007.

References 

  1. Owens GK. Regulation of differentiation of vascular smooth muscle cells. Physiol Rev. 1995;75:487–517
  2. Owens GK, Kumar MS, Wamhoff BR. Molecular regulation of vascular smooth muscle cell differentiation in development and disease. Physiol Rev. 2004;84:767–801
  3. Sobue K, Hayashi K, Nishida W. Expressional regulation of smooth muscle cell-specific genes in association with phenotypic modulation. Mol Cell Biochem. 1999;190:105–118
  4. Au YP, Kenagy RD, Clowes MM, Clowes AW. Mechanisms of inhibition by heparin of vascular smooth muscle cell proliferation and migration. Haemostasis. 1993;23(suppl 1):177–182
  5. Karnovsky MJ, Wright TC, Castellot JJ, Choay J, Lormeau JC, Petitou M. Heparin, heparan sulfate, smooth muscle cells, and atherosclerosis. Ann N Y Acad Sci. 1989;556:268–281
  6. Orlandi A, Ropraz P, Gabbiani G. Proliferative activity and alpha-smooth muscle actin expression in cultured rat aortic smooth muscle cells are differently modulated by transforming growth factor-beta 1 and heparin. Exp Cell Res. 1994;214:528–536
  7. Cook CL, Weiser MC, Schwartz PE, Jones CL, Majack RA. Developmentally timed expression of an embryonic growth phenotype in vascular smooth muscle cells. Circ Res. 1994;74:189–196
  8. Owens GK, Thompson MM. Developmental changes in isoactin expression in rat aortic smooth muscle cells in vivo (Relationship between growth and cytodifferentiation). J Biol Chem. 1986;261:13373–13380
  9. O'Brien ER, Alpers CE, Stewart DK, Ferguson M, Tran N, Gordon D, et al. Proliferation in primary and restenotic coronary atherectomy tissue (Implications for antiproliferative therapy). Circ Res. 1993;73:223–231
  10. Wilcox JN. Analysis of local gene expression in human atherosclerotic plaques. J Vasc Surg. 1992;15:913–916
  11. Clowes AW, Reidy MA, Clowes M. Mechanisms of stenosis after arterial injury. Lab Invest. 1983;49:208–215
  12. Newby AC, Zaltsman AB. Molecular mechanisms in intimal hyperplasia. J Pathol. 2000;190:300–309
  13. Marx SO, Marks AR. Bench to bedside: the development of rapamycin and its application to stent restenosis. Circulation. 2001;104:852–855
  14. Shah PK, Falk E, Badimon JJ, Fernandez-Ortiz A, Mailhac A, Villareal-Levy G, et al. Human monocyte-derived macrophages induce collagen breakdown in fibrous caps of atherosclerotic plaques (Potential role of matrix-degrading metalloproteinases and implications for plaque rupture). Circulation. 1995;92:1565–1569
  15. Folkman J, D'Amore PA. Blood vessel formation: what is its molecular basis?. Cell. 1996;87:1153–1155
  16. Hirschi KK, Rohovsky SA. D'Amore P (PDGF, TGF-beta, and heterotypic cell-cell interactions mediate endothelial cell-induced recruitment of 10T1/2 cells and their differentiation to a smooth muscle fate). J Cell Biol. 1998;141:805–814
  17. Risau W. Mechanisms of angiogenesis. Nature. 1997;386:671–674
  18. Heilmann C, Beyersdorf F, Lutter G. Collateral growth: cells arrive at the construction site. Cardiovasc Surg. 2002;10:570–578
  19. Powell RJ, Bhargava J, Basson MD, Sumpio BE. Coculture conditions alter endothelial modulation of TGF-beta 1 activation and smooth muscle growth morphology. Am J Physiol. 1998;274:H642–H649
  20. Powell RJ, Cronenwett JL, Fillinger MF, Wagner RJ, Sampson LN. Endothelial cell modulation of smooth muscle cell morphology and organizational growth pattern. Ann Vasc Surg. 1996;10:4–10
  21. Powell RJ, Hydowski J, Frank O, Bhargava J, Sumpio BE. Endothelial cell effect on smooth muscle cell collagen synthesis. J Surg Res. 1997;69:113–118
  22. Powell RJ, Sumpio BE. Regulation of smooth muscle cell differentiation and expression of nonmuscle myosin by endothelial cells in coculture. Surg Forum. 1997;408–410
  23. Fingerle J, Au YP, Clowes AW, Reidy MA. Intimal lesion formation in rat carotid arteries after endothelial denudation in absence of medial injury. Arteriosclerosis. 1990;10:1082–1087
  24. Nugent HM, Edelman ER. Endothelial implants provide long-term control of vascular repair in a porcine model of arterial injury. J Surg Res. 2001;99:228–234
  25. Zilla P. Endothelialization of vascular grafts. Curr Opin Cardiol. 1991;6:877–886
  26. Boerth NJ, Dey NB, Cornwell TL, Lincoln TM. Cyclic GMP-dependent protein kinase regulates vascular smooth muscle cell phenotype. J Vasc Res. 1997;34:245–259
  27. Brophy CM, Woodrum DA, Pollock J, Dickinson M, Komalavilas P, Cornwell TL, et al. cGMP-dependent protein kinase expression restores contractile function in cultured vascular smooth muscle cells. J Vasc Res. 2002;39:95–103
  28. Reusch HP, Schaefer M, Plum C, Schultz G, Paul M. Gbeta gamma mediate differentiation of vascular smooth muscle cells. J Biol Chem. 2001;276:19540–19547
  29. Hayashi K, Takahashi M, Kimura K, Nishida W, Saga H, Sobue K. Changes in the balance of phosphoinositide 3-kinase/protein kinase B (AKT) and the mitogen-activated protein kinases (ERK/p38MAPK) determine a phenotype of visceral and vascular smooth muscle cells. J Cell Biol. 1999;145:727–740
  30. Ohkawa Y, Hayashi K, Sobue K. Calcineurin-mediated pathway involved in the differentiated phenotype of smooth muscle cells. Biochem Biophys Res Commun. 2003;301:78–83
  31. Mano T, Luo Z, Malendowicz SL, Evans T, Walsh K. Reversal of GATA-6 downregulation promotes smooth muscle differentiation and inhibits intimal hyperplasia in balloon-injured rat carotid artery. Circ Res. 1999;84:647–654
  32. Morrisey EE. GATA-6: the proliferation stops here: cell proliferation in glomerular mesangial and vascular smooth muscle cells. Circ Res. 2000;87:638–640
  33. Perlman H, Suzuki E, Simonson M, Smith RC, Walsh K. GATA-6 induces p21(Cip1) expression and G1 cell cycle arrest. J Biol Chem. 1998;273:13713–13718
  34. Kakita T, Hasegawa K, Morimoto T, Kaburagi S, Wada H, Sasayama S. p300 protein as a coactivator of GATA-5 in the transcription of cardiac-restricted atrial natriuretic factor gene. J Biol Chem. 1999;274:34096–34102
  35. Obata H, Hayashi K, Nishida W, Momiyama T, Uchida A, Ochi T, et al. Smooth muscle cell phenotype-dependent transcriptional regulation of the alpha1 integrin gene. J Biol Chem. 1997;272:26643–26651
  36. Nishida W, Nakamura M, Mori S, Takahashi M, Ohkawa Y, Tadokoro S, et al. A triad of serum response factor and the GATA and NK families governs the transcription of smooth and cardiac muscle genes. J Biol Chem. 2002;277:7308–7317
  37. Wada H, Hasegawa K, Morimoto T, Kakita T, Yanazume T, Sasayama S. A p300 protein as a coactivator of GATA-6 in the transcription of the smooth muscle-myosin heavy chain gene. J Biol Chem. 2000;275:25330–25335
  38. Pipes GC, Creemers EE. Olson E (The myocardin family of transcriptional coactivators: versatile regulators of cell growth, migration, and myogenesis). Genes Dev. 2006;20:1545–1556
  39. Gingras AC, Raught B, Sonenberg N. mTOR signaling to translation. Curr Top Microbiol Immunol. 2004;279:169–197
  40. Podbielski J, Schoenberg L. Use of sirolimus in kidney transplantation. Prog Transplant. 2001;11:29–32
  41. Eisenberg MJ, Konnyu KJ. Review of randomized clinical trials of drug-eluting stents for the prevention of in-stent restenosis. Am J Cardiol. 2006;98:375–382
  42. Moliterno DJ. Healing Achilles--sirolimus versus paclitaxel. N Engl J Med. 2005;353:724–727
  43. Poon M, Marx SO, Gallo R, Badimon JJ, Taubman MB, Marks AR. Rapamycin inhibits vascular smooth muscle cell migration. J Clin Invest. 1996;98:2277–2283
  44. Marx SO, Jayaraman T, Go LO, Marks AR. Rapamycin-FKBP inhibits cell cycle regulators of proliferation in vascular smooth muscle cells. Circ Res. 1995;76:412–417
  45. Martin KA, Rzucidlo EM, Merenick BL, Fingar DC, Brown DJ, Wagner RJ, et al. The mTOR/p70 S6K1 pathway regulates vascular smooth muscle cell differentiation. Am J Physiol Cell Physiol. 2004;286:C507–C517
  46. Jacinto E, Hall MN. Tor signalling in bugs, brain and brawn. Nat Rev Mol Cell Biol. 2003;4:117–126
  47. Kanayasu-Toyoda T, Yamaguchi T, Uchida E, Hayakawa T. Commitment of neutrophilic differentiation and proliferation of HL-60 cells coincides with expression of transferrin receptor (Effect of granulocyte colony stimulating factor on differentiation and proliferation). J Biol Chem. 1999;274:25471–25480
  48. Yamamoto-Yamaguchi Y, Okabe-Kado J, Kasukabe T, Honma Y. Induction of differentiation of human myeloid leukemia cells by immunosuppressant macrolides (rapamycin and FK506) and calcium/calmodulin-dependent kinase inhibitors. Exp Hematol. 2001;29:582–588
  49. Gagnon A, Lau S, Sorisky A. Rapamycin-sensitive phase of 3T3-L1 preadipocyte differentiation after clonal expansion. J Cell Physiol. 2001;189:14–22
  50. Oh CD, Kim SJ, Ju JW, Song WK, Kim JH, Yoo YJ, et al. Immunosuppressant rapamycin inhibits protein kinase C alpha and p38 mitogen-activated protein kinase leading to the inhibition of chondrogenesis. Eur J Pharmacol. 2001;427:175–185
  51. Braun-Dullaeus RC, Mann MJ, Seay U, Zhang L, von Der Leyen HE, Morris RE, et al. Cell cycle protein expression in vascular smooth muscle cells in vitro and in vivo is regulated through phosphatidylinositol 3-kinase and mammalian target of rapamycin. Arterioscler Thromb Vasc Biol. 2001;21:1152–1158
  52. Martin KA, Blenis J. Coordinate regulation of translation by the PI 3-kinase and mTOR pathways. Adv Cancer Res. 2002;86:1–39
  53. Sarbassov DD, Ali SM, Sabatini D. Growing roles for the mTOR pathway. Curr Opin Cell Biol. 2005;17:596–603
  54. Harrington LS, Findlay GM, Lamb R. Restraining PI3K: mTOR signalling goes back to the membrane. Trends Biochem Sci. 2005;30:35–42
  55. Tremblay F, Marette A. Amino acid and insulin signaling via the mTOR/p70 S6 kinase pathway (A negative feedback mechanism leading to insulin resistance in skeletal muscle cells). J Biol Chem. 2001;276:38052–38060
  56. Tremblay F, Krebs M, Dombrowski L, Brehm A, Bernroider E, Roth E, et al. Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes. 2005;54:2674–2684
  57. Um SH, D'Alessio D, Thomas G. Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1. Cell Metab. 2006;3:393–402
  58. Greene MW, Garofalo RS. Positive and negative regulatory role of insulin receptor substrate 1 and 2 (IRS-1 and IRS-2) serine/threonine phosphorylation. Biochemistry. 2002;41:7082–7091
  59. Brown DJ, Rzucidlo EM, Merenick BL, Wagner RJ, Martin KA, Powell RJ. Endothelial cell activation of the smooth muscle cell phosphoinositide 3-kinase/AKT pathway promotes differentiation. J Vasc Surg. 2005;41:509–516
  60. Fillinger MF, Sampson LN, Cronenwett JL, Powell RJ, Wagner RJ. Coculture of endothelial cells and smooth muscle cells in bilayer and conditioned media models. J Surg Res. 1997;67:169–178
  61. Di Luozzo G, Bhargava J, Powell R. Vascular smooth muscle cell effect on endothelial cell endothelin-1 production. J Vasc Surg. 2000;31:781–789
  62. Vane J, Corin RE. Prostacyclin: a vascular mediator. Eur J Vasc Endovasc Surg. 2003;26:571–578
  63. Fetalvero KM, Shyu M, Nomikos AP, Chiu YF, Wagner RJ, Powell RJ, et al. The prostacyclin receptor induces human vascular smooth muscle cell differentiation via the protein kinase A pathway. Am J Physiol Heart Circ Physiol. 2006;290:H1337–H1346

 Competition of interest: none.

 Supported by grants K08HL076658-04 to Dr Rzucidlo and NIH NHLBI RO1-HL076612-01 to Dr Powell.

PII: S0741-5214(07)00412-0

doi: 10.1016/j.jvs.2007.03.001

Journal of Vascular Surgery
Volume 45, Issue 6, Supplement , Pages A25-A32 , June 2007

Article Tools

* Image Usage & Resolution